✦ LIBER ✦

The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor

✍ Scribed by R.L. Bell; P.R. Young; D. Albert; C. Lanni; J.B. Summers; D.W. Brooks; P. Rubin; G.W. Carter

Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 425 KB
Volume: 14
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(92)90182-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preparative separation and analysis of t

Preparative separation and analysis of the enantiomers of [14C]Zileuton, a 5-lipoxygenase inhibitor

✍ Samuel B. Thomas; Bruce W. Surber; Mike Fitzgerald 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 371 KB

The 5-Lipoxygenase Inhibitory Activity o

The 5-Lipoxygenase Inhibitory Activity of Zileuton in In Vitro and In Vivo Models of Antigen-Induced Airway Anaphylaxis

✍ P.E. Malo; R.L. Bell; T.K. Shaughnessy; J.B. Summers; D.W. Brooks; G.W. Carter 📂 Article 📅 1994 🏛 Elsevier 🌐 English ⚖ 417 KB

Leukotrienes are biologically active lipid mediators capable of producing airway inflammation, hyperresponsiveness and bronchoconstriction. The first enzyme in the metabolic pathway of arachidonic acid leading to the leukotrienes is 5-lipoxygenase (5-LO). A selective and potent 5-LO inhibitor, zileu

ChemInform Abstract: The Discovery of Ro

ChemInform Abstract: The Discovery of Rofecoxib, [MK 966, Vioxx®, 4-(4′-Methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an Orally Active Cyclooxygenase-2 Inhibitor.

✍ P. Prasit; Z. Wang; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

Discovery of a Potent, Selective and Ora

Discovery of a Potent, Selective and Orally Active Canine COX-2 Inhibitor, 2-(3-Difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.

✍ Jin Li; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 104 KB 👁 2 views

## Abstract For Abstract see ChemInform Abstract in Full Text.

ChemInform Abstract: SAR in the Alkoxy L

ChemInform Abstract: SAR in the Alkoxy Lactone Series: The Discovery of DFP, a Potent and Orally Active COX-2 Inhibitor.

✍ Y. Leblanc; P. Roy; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB 👁 2 views

The Discovery of SB-435495: A Potent, Or

The Discovery of SB-435495: A Potent, Orally Active Inhibitor of Lipoprotein-Associated Phospholipase A2 for Evaluation in Man.

✍ Stephen A. Smith; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 66 KB 👁 1 views